You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Biomarkers and severe asthma: a critical appraisal
|
|---|---|
| Published in |
Clinical and Molecular Allergy, October 2015
|
| DOI | 10.1186/s12948-015-0027-7 |
| Pubmed ID | |
| Authors |
Alessandra Chiappori, Laura De Ferrari, Chiara Folli, Pierluigi Mauri, Anna Maria Riccio, Giorgio Walter Canonica |
| Abstract |
Severe asthma (SA) is a clinically and etiologically heterogeneous respiratory disease which affects among 5-10 % of asthmatic patients. Despite high-dose therapy, a large patients percentage is not fully controlled and has a poor quality of life. In this review, we describe the biomarkers actually known in scientific literature and used in clinical practice for SA assessment and management: neutrophils, eosinophils, periostin, fractional exhaled nitric oxide, exhaled breath condensate and galectins. Moreover, we give an overview on clinical and biological features characterizing severe asthma, paying special attention to the potential use of these ones as reliable markers. We finally underline the need to define different biomarkers panels to select patients affected by severe asthma for specific and personalized therapeutic approach. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 67% |
| Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | <1% |
| Unknown | 103 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 18% |
| Student > Ph. D. Student | 16 | 15% |
| Other | 15 | 14% |
| Student > Master | 12 | 12% |
| Student > Bachelor | 7 | 7% |
| Other | 23 | 22% |
| Unknown | 12 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 46 | 44% |
| Biochemistry, Genetics and Molecular Biology | 7 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
| Immunology and Microbiology | 5 | 5% |
| Nursing and Health Professions | 4 | 4% |
| Other | 19 | 18% |
| Unknown | 17 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2015.
All research outputs
#14,239,245
of 22,829,683 outputs
Outputs from Clinical and Molecular Allergy
#156
of 214 outputs
Outputs of similar age
#142,183
of 274,923 outputs
Outputs of similar age from Clinical and Molecular Allergy
#5
of 6 outputs
Altmetric has tracked 22,829,683 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 214 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,923 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.